Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccines against human enteric bacterial pathogens.

Gordon Dougan1, Alan Huett, Simon Clare

  • 1Centre for Molecular Microbiology and Infection, Department of Biological Sciences, Imperial College of Science, Technology and Medicine, London, UK.

British Medical Bulletin
|August 15, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary inflammation in severe pneumonia is characterised by compartmentalised and mechanistically distinct sub-phenotypes.

Nature communications·2026
Same author

Whole-genome sequencing to investigate the prevalence and transmission of multidrug-resistant Gram-negative pathogens in an adult intensive care unit in the UK.

Microbial genomics·2026
Same author

A disease model resource reveals core principles of tissue-specific cancer evolution.

Nature·2026
Same author

Vaccines and antimicrobial resistance: from science to policy-summary and outcomes.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2026
Same author

A Novel Human Cellular System for Studying Normal Aging and for Anti-Aging Discovery.

Aging cell·2026
Same author

Tumor suppressor protein p53 governs human trophoblast lineage development.

Cell reports·2025

Developing effective gut vaccines against numerous enteric bacterial pathogens is difficult. New oral and injectable vaccines are in early trials but face significant hurdles before widespread use.

Area of Science:

  • Microbiology
  • Immunology
  • Vaccinology

Background:

  • Enteric bacterial pathogens pose a significant global health burden.
  • Inducing effective gut immunity is a major challenge for vaccine development.
  • A diverse range of pathogens necessitates broad-spectrum vaccine strategies.

Purpose of the Study:

  • To review the challenges and progress in developing vaccines against enteric bacterial pathogens.
  • To discuss the current state of novel enteric vaccine candidates.
  • To identify technical barriers hindering the clinical translation of these vaccines.

Main Methods:

  • Literature review of current research on enteric vaccines.
  • Analysis of early-phase clinical trial data for novel vaccine platforms.

Related Experiment Videos

  • Identification of key technical and immunological challenges.

    • Main Results:

    • New generations of enteric vaccines (live and non-living antigens) are entering clinical evaluation.
    • Both oral and injectable delivery routes are being explored.
    • Significant technical challenges remain for successful vaccine implementation.

    Conclusions:

    • Despite promising early-stage developments, substantial barriers impede the widespread availability of enteric vaccines.
    • Overcoming these hurdles is crucial for advancing gut health and preventing enteric infections.
    • Continued research and development are necessary to translate promising vaccine candidates into public health solutions.